Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


Quantifying changes in global health inequality: the Gini and Slope Inequality Indices applied to the Global Burden of Disease data, 1990-2017.

Steinbeis F, Gotham D, von Philipsborn P, Stratil JM.

BMJ Glob Health. 2019 Sep 24;4(5):e001500. doi: 10.1136/bmjgh-2019-001500. eCollection 2019.


Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List.

Gotham D, Barber MJ, Hill AM.

BMJ Open. 2019 Sep 30;9(9):e027780. doi: 10.1136/bmjopen-2018-027780.


Patent pooling to increase access to essential medicines.

Burrone E, Gotham D, Gray A, de Joncheere K, Magrini N, Martei YM, Gore C, Kieny MP.

Bull World Health Organ. 2019 Aug 1;97(8):575-577. doi: 10.2471/BLT.18.229179. Epub 2019 Jun 11. No abstract available.


Production costs and potential prices for biosimilars of human insulin and insulin analogues.

Gotham D, Barber MJ, Hill A.

BMJ Glob Health. 2018 Sep 25;3(5):e000850. doi: 10.1136/bmjgh-2018-000850. eCollection 2018.


Cell line access to revolutionize the biosimilars market.

Gotham D.

F1000Res. 2018 May 3;7:537. doi: 10.12688/f1000research.14808.1. eCollection 2018.


Estimated costs of production and potential prices for the WHO Essential Medicines List.

Hill AM, Barber MJ, Gotham D.

BMJ Glob Health. 2018 Jan 29;3(1):e000571. doi: 10.1136/bmjgh-2017-000571. eCollection 2018.


Candidates for inclusion in a universal antiretroviral regimen: tenofovir alafenamide.

Gotham D, Hill A, Pozniak AL.

Curr Opin HIV AIDS. 2017 Jul;12(4):324-333. doi: 10.1097/COH.0000000000000379. Review.


Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis.

Hill A, Redd C, Gotham D, Erbacher I, Meldrum J, Harada R.

BMJ Open. 2017 Jan 20;7(1):e011965. doi: 10.1136/bmjopen-2016-011965.


Estimated generic prices for novel treatments for drug-resistant tuberculosis.

Gotham D, Fortunak J, Pozniak A, Khoo S, Cooke G, Nytko FE 3rd, Hill A.

J Antimicrob Chemother. 2017 Apr 1;72(4):1243-1252. doi: 10.1093/jac/dkw522.


Open letter to the candidates for Director-General of WHO: will you support a patient-centred R&D agreement?

Barber MJ, Gotham D, MuntanyĆ  J, Balasubramaniam T; 18 other signatories.

Lancet Glob Health. 2017 Feb;5(2):e135-e136. doi: 10.1016/S2214-109X(16)30353-9. Epub 2016 Dec 10. No abstract available.


Drug prices threaten the NHS.

Ress M, Levi J, McDonald D, Piears J, Gotham D.

Lancet. 2016 Nov 26;388(10060):2603-2604. doi: 10.1016/S0140-6736(16)32119-5. Epub 2016 Nov 8. No abstract available.


Global health equity in United Kingdom university research: a landscape of current policies and practices.

Gotham D, Meldrum J, Nageshwaran V, Counts C, Kumari N, Martin M, Beattie B, Post N.

Health Res Policy Syst. 2016 Oct 10;14(1):76.


Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C.

Hill A, Simmons B, Gotham D, Fortunak J.

J Virus Erad. 2016 Jan 1;2(1):28-31.


How the MDGs gave up on measuring access to medicines.

Gotham D, Onarheim KH, Barber MJ.

Lancet Glob Health. 2016 May;4(5):e296-7. doi: 10.1016/S2214-109X(16)00066-8. No abstract available.


Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment.

Hill A, Gotham D, Fortunak J, Meldrum J, Erbacher I, Martin M, Shoman H, Levi J, Powderly WG, Bower M.

BMJ Open. 2016 Jan 27;6(1):e009586. doi: 10.1136/bmjopen-2015-009586.


Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries.

Hill A, Gotham D, Cooke G, Bhagani S, Andrieux-Meyer I, Cohn J, Fortunak J.

J Virus Erad. 2015 Apr 1;1(2):103-10.


Influence of prior fasciotomy on infection after open reduction and internal fixation of tibial plateau fractures.

Hak DJ, Lee M, Gotham DR.

J Trauma. 2010 Oct;69(4):886-8. doi: 10.1097/TA.0b013e3181b83fe9.


Supplemental Content

Loading ...
Support Center